Old Web
English
Sign In
Acemap
>
Paper
>
An open-label phase I dose-finding study of APR-246 in hematological malignancies
An open-label phase I dose-finding study of APR-246 in hematological malignancies
2016
Stefan Deneberg
Honar Cherif
Vladimir Lazarevic
P.-O. Andersson
M. von Euler
Gunnar Juliusson
Sören Lehmann
Keywords:
Cancer research
Immunology
Lymphoma
Leukemia
Stem cell
Fusion gene
Apoptosis
Haematopoiesis
Hematology
Medicine
Internal medicine
open label
translational biology
dose finding
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
50
Citations
NaN
KQI
[]